James Kwiatkowski
Psychiatric/Mental Health · Richmond, VANPI 1225607906
Payments from drug & device makers
Across 129 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$594
- Teva Pharmaceuticals USA, Inc.$240
- Otsuka America Pharmaceutical, Inc.$193
- E.r. Squibb & Sons, L.L.C.$149
- Neurocrine Biosciences, Inc.$131
- Corium, LLC$129
- plus $837 from 14 others
What the payments were for
- Food & beverage$2,272100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $594 |
| Teva Pharmaceuticals USA, Inc. | 5 | $240 |
| Otsuka America Pharmaceutical, Inc. | 9 | $193 |
| E.r. Squibb & Sons, L.L.C. | 7 | $149 |
| Neurocrine Biosciences, Inc. | 6 | $131 |
| Corium, LLC | 6 | $129 |
| Johnson & Johnson | 4 | $109 |
| Neuronetics, Inc. | 3 | $92 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Lundbeck LLC | 3 | $75 |
| Ironshore Pharmaceuticals Inc. | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Almatica Pharma LLC | 3 | $58 |
| Harmony Biosciences LLC | 2 | $48 |
| TMS Neurohealth Centers Inc. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $15 |
How this compares
$2,272 in reported general payments places this provider in the 80th percentile of 1,003 psychiatric/mental health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 18 | $4,449 |
| Aripiprazole | 43 | $1,660 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $1,377 |
| Pimozide | 11 | $889 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $355 |
| Bupropion XlBupropion Hcl | 21 | $334 |
| Clonazepam | 43 | $300 |
| Duloxetine Hcl | 28 | $294 |
| Amitriptyline Hcl | 20 | $221 |
| Hydroxyzine Hcl | 12 | $194 |
| Alprazolam | 34 | $163 |
| Temazepam | 11 | $159 |
| Buspirone Hcl | 34 | $139 |
| Eszopiclone | 22 | $138 |
| Lamotrigine | 15 | $128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $58 | $5532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,003 psychiatric/mental health providers in Virginia.
Other psychiatric/mental health in Richmond
- Tonjanika BoydRichmond$40K
- Kirby PatmonRichmond$36K
- Abbie SmithRichmond$14K
- Thomas MamalakisRichmond$12K
- Monica MeyerRichmond$11K
- Vicky SpillerRichmond$10K
- Kimberly Southam-GerowRichmond$8K
- Charles McDonoughRichmond$7K
- Nympha DalgadoRichmond$7K
- Justin RayChesapeake$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.